- GreenLight Biosciences ( NASDAQ: GRNA ) announced a private placement of ~$109M; financing includes participation from new and existing institutional investors.
- The company has agreed to sell ~27.8M shares to a select group of institutional and accredited investors at $3.92/share.
- The company plans to use the net proceeds from the financing to advance its development of research and commercial programs and for working capital and general corporate purposes.
- The proceeds from this financing, combined with current cash and equivalents, is expected to be sufficient to fund operations through the 1H23.
- Shares trading 2.8% higher premarket.
For further details see:
GreenLight Biosciences launches $109M in financing